NVCR - NovoCure's (NVCR) CEO Asaf Danziger on Q4 2021 Results - Earnings Call Transcript

NovoCure Limited (NVCR) Q4 2021 Earnings Conference Call February 24, 2022 8:00 AM ET Company Participants Ingrid Goldberg – Vice President of Finance and Investor Relations Bill Doyle – Executive Chairman Asaf Danziger – Chief Executive Officer Ashley Cordova – Chief Financial Officer Wilco Groenhuysen – Chief Operating Officer Ely Benaim – Chief Medical Officer Pritesh Shah – Chief Commercial Officer Uri Weinberg – Chief Science Officer Conference Call Participants Jason Bednar – Piper Sandler Gavin Scott – JPMorgan Kevin DeGeeter – Oppenheimer Lei Huang – Wells Fargo Greg Fraser – Truist Securities Jason Wittes – Loop Capital Vijay Kumar – Evercore ISI Presentation Operator Good day, and thank you for standing by. Welcome to NovoCure Fourth Quarter and Full Year 2021 Earnings Conference Call. At this time, all participants are in listen-only mode. After the presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised today’s conference

For further details see:

NovoCure's (NVCR) CEO Asaf Danziger on Q4 2021 Results - Earnings Call Transcript